{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:44:44Z","timestamp":1765079084158},"reference-count":95,"publisher":"Oxford University Press (OUP)","issue":"947","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Exacerbations of chronic obstructive pulmonary disease impose a considerable burden of morbidity, mortality, and health care cost. Management guidelines outlining best practice, based largely on consensus expert opinion, were produced by a number of organisations during the last decade. Current interest in the field is high. This has resulted in the publication of many further studies which have extended our understanding of the pathology involved and provided, for the first time, an evidence base for many of the therapeutic options. In this review we aim to bring the non-specialist reader up to date with current management principles and the evidence underlying such interventions.<\/jats:p>","DOI":"10.1136\/pgmj.2004.019182","type":"journal-article","created":{"date-parts":[[2004,9,8]],"date-time":"2004-09-08T17:02:32Z","timestamp":1094662952000},"page":"497-505","source":"Crossref","is-referenced-by-count":22,"title":["Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation"],"prefix":"10.1093","volume":"80","author":[{"given":"J R","family":"Hurst","sequence":"first","affiliation":[{"name":"Academic Unit of Respiratory Medicine, St Bartholomew\u2019s Hospital , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A","family":"Wedzicha","sequence":"additional","affiliation":[{"name":"Academic Unit of Respiratory Medicine, St Bartholomew\u2019s Hospital , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,9,8]]},"reference":[{"key":"2023050810454424900_R1","volume-title":"Global initiative for chronic obstructive lung disease","author":"Pauwels","year":"2001"},{"key":"2023050810454424900_R2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1183\/09031936.03.00038303","article-title":"Longitudinal changes in the nature, severity and frequency of COPD exacerbations","volume":"22","author":"Donaldson","year":"2003","journal-title":"Eur Respir J"},{"key":"2023050810454424900_R3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1183\/09031936.93.02080710","article-title":"Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease","volume":"2","author":"Vestbo","year":"1989","journal-title":"Eur Respir J"},{"key":"2023050810454424900_R4","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R5","doi-asserted-by":"crossref","first-page":"398S","DOI":"10.1378\/chest.117.5_suppl_2.398S","article-title":"Toward a consensus definition for COPD exacerbations","volume":"117","author":"Roisin","year":"2000","journal-title":"Chest"},{"key":"2023050810454424900_R6","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1164\/ajrccm.164.9.2105011","article-title":"Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease","volume":"164","author":"Seemungal","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1164\/ajrccm.162.1.9911019","article-title":"Respiratory viral infections in adults with and without chronic obstructive pulmonary disease","volume":"162","author":"Greenberg","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1034\/j.1399-3003.1999.13d25.x","article-title":"Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease","volume":"13","author":"Donaldson","year":"1999","journal-title":"Eur Respir J"},{"key":"2023050810454424900_R9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1034\/j.1399-3003.2000.16d19.x","article-title":"Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease","volume":"16","author":"Seemungal","year":"2000","journal-title":"Eur Respir J"},{"key":"2023050810454424900_R10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1034\/j.1399-3003.1999.13b21.x","article-title":"Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease","volume":"13","author":"Zalacain","year":"1999","journal-title":"Eur Respir J"},{"key":"2023050810454424900_R11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/thorax.57.9.759","article-title":"Relationship between bacterial colonisation and the frequency, character and severity of COPD exacerbations","volume":"57","author":"Patel","year":"2002","journal-title":"Thorax"},{"key":"2023050810454424900_R12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1164\/rccm.200210-1179OC","article-title":"Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease","volume":"167","author":"Wilkinson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMoa012561","article-title":"New strains of bacteria and exacerbations of chronic obstructive pulmonary disease","volume":"347","author":"Sethi","year":"2002","journal-title":"N Engl J Med"},{"key":"2023050810454424900_R14","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1378\/chest.117.6.1638","article-title":"Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD","volume":"117","author":"Stockley","year":"2000","journal-title":"Chest"},{"key":"2023050810454424900_R15","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1183\/09031936.97.10051064","article-title":"Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project","volume":"10","author":"Anderson","year":"1997","journal-title":"Eur Respir J"},{"key":"2023050810454424900_R16","volume-title":"Trends in emergency hospital admissions for lung disease","author":"Lung and Asthma Information Agency"},{"key":"2023050810454424900_R17","first-page":"661","article-title":"In-patient workload in medical specialities\u20142. Profiles of individual diagnoses from linked statistics","volume":"88","author":"Ashton","year":"1995","journal-title":"Q J Med"},{"key":"2023050810454424900_R18","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1164\/ajrccm.154.4.8887592","article-title":"Outcomes following acute exacerbation of severe chronic obstructive lung disease","volume":"154","author":"Connors","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1164\/ajrccm.164.3.2010017","article-title":"Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Results from the Lung Health Study","volume":"164","author":"Kanner","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"2023050810454424900_R21","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1378\/chest.117.2_suppl.5S","article-title":"The economic burden of COPD","volume":"117","author":"Sullivan","year":"2000","journal-title":"Chest"},{"key":"2023050810454424900_R22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1164\/ajrccm\/136.1.225","article-title":"Standards for the diagnosis of patients with chronic obstructive pulmonary disease (COPD) and asthma","volume":"136","author":"American Thoracic Society","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"suppl A","key":"2023050810454424900_R23","doi-asserted-by":"crossref","first-page":"11A","DOI":"10.1155\/2003\/567598","article-title":"Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease\u20142003","volume":"10","author":"Donnell","year":"2003","journal-title":"Can Respir J"},{"key":"2023050810454424900_R24","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1183\/09031936.95.08081398","article-title":"Optimal assessment and management of chronic obstructive pulmonary disease","volume":"8","author":"European Respiratory Society Task Force","year":"1995","journal-title":"Eur Respir J"},{"issue":"suppl 5","key":"2023050810454424900_R25","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/thx.52.2008.S1.5","article-title":"BTS guidelines for the management of chronic obstructive pulmonary disease","volume":"52","author":"COPD Guidelines Group of the Standards of Care Committee of the BTS","year":"1997","journal-title":"Thorax"},{"key":"2023050810454424900_R26","first-page":"i1","article-title":"Chronic obstructive pulmonary disease (COPD): management of chronic obstructive pulmonary disease in primary and secondary care","volume":"59","author":"National Institute for Clinical Excellence","year":"2004","journal-title":"Thorax"},{"key":"2023050810454424900_R27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(80)91008-9","article-title":"Respiratory failure revisited: acute exacerbations of chronic bronchitis between 1961\u201368 and 1970\u201376","volume":"i","author":"Warren","year":"1980","journal-title":"Lancet"},{"key":"2023050810454424900_R28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1164\/ajrccm.153.3.8630581","article-title":"Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease","volume":"153","author":"Belman","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archinte.1989.00390030044008","article-title":"A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease","volume":"149","author":"Braun","year":"1989","journal-title":"Arch Intern Med"},{"key":"2023050810454424900_R30","article-title":"Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease (Cochrane methodology review)","volume-title":"The Cochrane Library","author":"McCrory","year":"2003"},{"key":"2023050810454424900_R31","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/archinte.1997.00440360162018","article-title":"Bronchodilator delivery in acute airflow obstruction. A meta-analysis","volume":"157","author":"Turner","year":"1997","journal-title":"Arch Intern Med"},{"key":"2023050810454424900_R32","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1001\/archinte.1996.00440170131014","article-title":"A review and economic evaluation of bronchodilator delivery methods in hospitalized patients","volume":"156","author":"Turner","year":"1996","journal-title":"Arch Intern Med"},{"key":"2023050810454424900_R33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0196-0644(95)70071-4","article-title":"Comparative trial of continuous nebulization versus metered-dose inhaler in the treatment of acute bronchospasm","volume":"26","author":"Levitt","year":"1995","journal-title":"Ann Emerg Med"},{"key":"2023050810454424900_R34","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1164\/ajrccm.150.6.7952628","article-title":"Airway eosinophilia in chronic bronchitis during exacerbations","volume":"150","author":"Saetta","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/thorax.55.2.114","article-title":"Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations","volume":"55","author":"Bhowmik","year":"2000","journal-title":"Thorax"},{"key":"2023050810454424900_R36","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1001\/archinte.162.22.2527","article-title":"Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease. A systematic review","volume":"162","author":"Singh","year":"2002","journal-title":"Arch Intern Med"},{"key":"2023050810454424900_R37","volume-title":"The Cochrane Library","author":"Wood-Baker","year":"2003"},{"key":"2023050810454424900_R38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1378\/chest.98.4.845","article-title":"Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD. Effect on patients with a history of multiple relapses","volume":"98","author":"Murata","year":"1990","journal-title":"Chest"},{"key":"2023050810454424900_R39","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.161.5.9908022","article-title":"Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease","volume":"161","author":"Seemungal","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R40","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0140-6736(93)90134-3","article-title":"Double-blind trial of steroid tapering in acute asthma","volume":"341","author":"Driscoll","year":"1993","journal-title":"Lancet"},{"key":"2023050810454424900_R41","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199906243402502","article-title":"Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease","volume":"340","author":"Niewoehner","year":"1999","journal-title":"N Engl J Med"},{"key":"2023050810454424900_R42","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-92-6-753","article-title":"Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency","volume":"92","author":"Albert","year":"1980","journal-title":"Ann Intern Med"},{"key":"2023050810454424900_R43","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1164\/ajrccm.165.5.2109093","article-title":"Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease. A randomized controlled trial","volume":"165","author":"Maltais","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med"},{"key":"2023050810454424900_R45","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/thx.50.7.758","article-title":"Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice","volume":"50","author":"Sachs","year":"1995","journal-title":"Thorax"},{"key":"2023050810454424900_R46","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jama.1995.03520360071042","article-title":"Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis","volume":"273","author":"Saint","year":"1995","journal-title":"JAMA"},{"key":"2023050810454424900_R47","first-page":"22S","article-title":"Effects of antibiotics on the recurrence rates of chronic obstructive pulmonary disease exacerbations","volume":"112","author":"Adam","year":"1997","journal-title":"Chest"},{"issue":"suppl A","key":"2023050810454424900_R48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/jac\/43.suppl_1.107","article-title":"Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis","volume":"43","author":"Destache","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"2023050810454424900_R49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jac\/28.2.249","article-title":"Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamellea) catarrhalis isolated in the UK from sputa","volume":"28","author":"Powell","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"2023050810454424900_R50","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1155\/2000\/417298","article-title":"Outpatient antibiotic therapy and short term mortality in elderly patients with chronic obstructive pulmonary disease","volume":"7","author":"Sin","year":"2000","journal-title":"Can Respir J"},{"key":"2023050810454424900_R51","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.327.7416.643","article-title":"Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials","volume":"327","author":"Barr","year":"2003","journal-title":"BMJ"},{"key":"2023050810454424900_R52","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/thx.51.10.1048","article-title":"Comparison of the acute effects on gas exchange of nasal ventilation and doxapram in exacerbations of chronic obstructive pulmonary disease","volume":"51","author":"Angus","year":"1996","journal-title":"Thorax"},{"issue":"4","key":"2023050810454424900_R53","article-title":"Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease (Cochrane methodology review)","author":"Greenstone","year":"2003","journal-title":"The Cochrane Library"},{"key":"2023050810454424900_R54","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1183\/09031936.97.10061285","article-title":"Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease","volume":"10","author":"Barbera","year":"1997","journal-title":"Eur Respir J"},{"key":"2023050810454424900_R55","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/thorax.55.7.550","article-title":"One year period prevalence study of respiratory acidosis in acute exacerbation of COPD: implications for the provision of non-invasive ventilation and oxygen administration","volume":"55","author":"Plant","year":"2000","journal-title":"Thorax"},{"key":"2023050810454424900_R56","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/ajrccm.161.5.9904119","article-title":"The role of hypoventilation and ventilation-perfusion redistribution in oxygen-induced hypercapnia during acute exacerbations of chronic obstructive pulmonary disease","volume":"161","author":"Robinson","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R57","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(00)04049-6","article-title":"Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease","volume":"357","author":"Moloney","year":"2001","journal-title":"Lancet"},{"key":"2023050810454424900_R58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/thx.50.4.405","article-title":"Compliance at night with low flow oxygen therapy: a comparison of nasal cannulae and Venturi face masks","volume":"50","author":"Costello","year":"1995","journal-title":"Thorax"},{"key":"2023050810454424900_R59","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1034\/j.1399-3003.1999.14d34.x","article-title":"Oxygen therapy during exacerbations of chronic obstructive pulmonary disease","volume":"14","author":"Agusti","year":"1999","journal-title":"Eur Respir J"},{"key":"2023050810454424900_R60","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1183\/09031936.98.11030712","article-title":"Blood gas measurement during exercise: a comparative study between arterialized earlobe sampling and direct arterial puncture in adults","volume":"11","author":"Fajac","year":"1998","journal-title":"Eur Respir J"},{"key":"2023050810454424900_R61","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/0140-6736(93)90696-E","article-title":"Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease","volume":"341","author":"Bott","year":"1993","journal-title":"Lancet"},{"key":"2023050810454424900_R62","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM199509283331301","article-title":"Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease","volume":"333","author":"Brochard","year":"1995","journal-title":"N Engl J Med"},{"key":"2023050810454424900_R63","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1164\/ajrccm.151.6.7767523","article-title":"Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure","volume":"151","author":"Kramer","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R64","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0140-6736(00)02323-0","article-title":"Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial","volume":"355","author":"Plant","year":"2000","journal-title":"Lancet"},{"key":"2023050810454424900_R65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/bmj.326.7382.185","article-title":"Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis","volume":"326","author":"Lightowler","year":"2003","journal-title":"BMJ"},{"key":"2023050810454424900_R66","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1097\/00003246-200006000-00072","article-title":"Noninvasive positive pressure ventilation in the setting of severe, acute exacerbations of chronic obstructive pulmonary disease: more effective and less expensive","volume":"28","author":"Keenan","year":"2000","journal-title":"Crit Care Med"},{"key":"2023050810454424900_R67","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/bmj.326.7396.956","article-title":"Cost effectiveness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomised controlled trial","volume":"326","author":"Plant","year":"2003","journal-title":"BMJ"},{"key":"2023050810454424900_R68","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jama.287.3.345","article-title":"Characteristics and outcomes in adult patients receiving mechanical ventilation. A 28-day international study","volume":"287","author":"Esteban","year":"2002","journal-title":"JAMA"},{"key":"2023050810454424900_R69","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1164\/ajrccm.161.4.9812160","article-title":"Physiologic determinants of ventilator dependence in long-term mechanically ventilated patients","volume":"161","author":"Purro","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R70","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-128-9-199805010-00004","article-title":"Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial","volume":"128","author":"Nava","year":"1998","journal-title":"Ann Intern Med"},{"key":"2023050810454424900_R71","article-title":"Heliox for treatment of exacerbations of chronic obstructive pulmonary disease (Cochrane review)","volume-title":"The Cochrane Library","author":"Rodrigo","year":"2003"},{"key":"2023050810454424900_R72","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/ajrccm.164.6.2006012","article-title":"Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM Study","volume":"164","author":"Garcia-Aymerich","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R73","volume-title":"The Cochrane Library","author":"Ram","year":"2003"},{"key":"2023050810454424900_R74","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1136\/bmj.316.7147.1786","article-title":"Randomised controlled trial comparing hospital at home care with inpatient hospital care. I: three month follow up of health outcomes","volume":"316","author":"Shepperd","year":"1998","journal-title":"BMJ"},{"key":"2023050810454424900_R75","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(97)03471-5","article-title":"Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease","volume":"351","author":"Paggiaro","year":"1998","journal-title":"Lancet"},{"key":"2023050810454424900_R76","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial","volume":"320","author":"Burge","year":"2000","journal-title":"BMJ"},{"key":"2023050810454424900_R77","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(98)10019-3","article-title":"Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial","volume":"353","author":"Vestbo","year":"1999","journal-title":"Lancet"},{"key":"2023050810454424900_R78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0954-6111(99)90001-X","article-title":"An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease","volume":"93","author":"Jarad","year":"1999","journal-title":"Respir Med"},{"key":"2023050810454424900_R79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9343(02)01143-9","article-title":"The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials","volume":"113","author":"Alsaeedi","year":"2002","journal-title":"Am J Med"},{"key":"2023050810454424900_R80","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy. A systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"key":"2023050810454424900_R81","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1164\/ajrccm.162.1.9909066","article-title":"Withdrawal of chronic systemic corticosteroids in patients with COPD. A randomized trial","volume":"162","author":"Rice","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R82","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1378\/chest.115.4.957","article-title":"Efficacy of salmeterol xinafoate in the treatment of COPD","volume":"115","author":"Mahler","year":"1999","journal-title":"Chest"},{"key":"2023050810454424900_R83","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1183\/09031936.02.00238702","article-title":"Improved health outcomes in patients with COPD during 1 years treatment with tiotropium","volume":"19","author":"Vincken","year":"2002","journal-title":"Eur Respir J"},{"key":"2023050810454424900_R84","volume-title":"The Cochrane Library","author":"Poole","year":"2003"},{"key":"2023050810454424900_R85","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-104-1-106","article-title":"Pneumococcal vaccine and patients with chronic lung disease","volume":"104","author":"Williams","year":"1986","journal-title":"Ann Intern Med"},{"key":"2023050810454424900_R86","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1378\/chest.92.2.204","article-title":"Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study","volume":"92","author":"Davis","year":"1987","journal-title":"Chest"},{"key":"2023050810454424900_R87","volume-title":"The Cochrane Library","author":"Staykova","year":"2003"},{"issue":"4","key":"2023050810454424900_R88","article-title":"Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease (Cochrane review)","author":"Poole","year":"2003","journal-title":"The Cochrane Library"},{"key":"2023050810454424900_R89","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1164\/ajrccm.156.6.9612096","article-title":"Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease","volume":"156","author":"Collet","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050810454424900_R90","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1183\/09031936.99.13112599","article-title":"Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction","volume":"13","author":"Foglio","year":"1999","journal-title":"Eur Respir J"},{"key":"2023050810454424900_R91","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1378\/chest.117.4.976","article-title":"Long-term effects of outpatient rehabilitation of COPD. A randomised trial","volume":"117","author":"Guell","year":"2000","journal-title":"Chest"},{"key":"2023050810454424900_R92","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1378\/chest.105.1.100","article-title":"Nasal intermittent positive pressure ventilation. long-term follow-up in patients with severe chronic respiratory insufficiency","volume":"105","author":"Leger","year":"1994","journal-title":"Chest"},{"key":"2023050810454424900_R93","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/thx.53.6.495","article-title":"Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: long term follow up and effect on survival","volume":"53","author":"Jones","year":"1998","journal-title":"Thorax"},{"key":"2023050810454424900_R94","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1183\/09031936.97.10122835","article-title":"Domiciliary nasal intermittent positive pressure ventilation in severe COPD: effects on lung function and quality of life","volume":"10","author":"Perrin","year":"1997","journal-title":"Eur Respir J"},{"key":"2023050810454424900_R95","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/thorax.58.10.867","article-title":"Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis","volume":"58","author":"Tuggey","year":"2003","journal-title":"Thorax"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/80\/947\/497\/50224557\/postgradmedj-80-497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/80\/947\/497\/50224557\/postgradmedj-80-497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T10:47:35Z","timestamp":1683542855000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/80\/947\/497\/7036150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":95,"journal-issue":{"issue":"947","published-online":{"date-parts":[[2004,9,8]]},"published-print":{"date-parts":[[2004,9,8]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2004.019182","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"value":"1469-0756","type":"electronic"},{"value":"0032-5473","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,9]]},"published":{"date-parts":[[2004,9]]}}}